Pharmaceutical Preparation Manufacturing
Lilly(Eli) & Co
% of Portfolio
6.7%
Average Buy Price
$724.56
+56.8%
Current Price
$1,136.37
Q1 2026
Sold 26.6% shares
6.7% of Portfolio
Sold 26.6% in Q1 2026
Avg closing price
Price range
See more trades by signing up for free
Google
Facebook
Or continue with email
View all investments of Polen Capital
